Rapid Treatment of Anhedonia With Pramipexole as Adjunct to Buprenorphine in Opioid Use Disorder

Clare E. Laubenthal, PA-C; Rodrigo Escalona, MD; Jaclyn E. Welch, PMHNP-BC

Prim Care Companion CNS Disord 2023;25(5):22cr03535

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

References (12)

Sullivan MD. Depression effects on long-term prescription opioid use, abuse, and addiction. Clin J Pain. 2018;34(9):878–884. PubMed CrossRef
Hudson TJ, Painter JT, Gressler LE, et al. Factors associated with opioid initiation in OEF/OIF/OND veterans with traumatic brain injury. Pain Med. 2018;19(4):774–787. PubMed CrossRef
Martinotti G, Cloninger CR, Janiri L. Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects. Am J Drug Alcohol Abuse. 2008;34(2):177–183. PubMed CrossRef
Fujiwara S, Kimura F, Hosokawa T, et al. Anhedonia in Japanese patients with Parkinson’s disease. Geriatr Gerontol Int. 2011;11(3):275–281. PubMed CrossRef
Lemke MR, Brecht HM, Koester J, et al. Anhedonia, depression, and motor functioning in Parkinson’s disease during treatment with pramipexole. J Neuropsychiatry Clin Neurosci. 2005;17(2):214–220. PubMed CrossRef
Willner P, Lappas S, Cheeta S, et al. Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology (Berl). 1994;115(4):454–462. PubMed CrossRef
Escalona R, Fawcett J, Rush AJ. Pramipexole augmentation of buprenorphine improves pain and depression in opioid use disorder: a case report. Prim Care Companion CNS Disord. 2020;22(5):20l02598. PubMed CrossRef
Williams JBW, Kobak KA. Development and reliability of a structured interview guide for the Montgomery-Asberg Depression Rating Scale (SIGMA). Br J Psychiatry. 2008;192(1):52–58. PubMed CrossRef
Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005;52(8):2495–2505. PubMed CrossRef
Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129–138. PubMed
Keetharuth AD, Brazier J, Connell J, et al. Recovering Quality of Life (ReQoL): a new generic self-reported outcome measure for use with people experiencing mental health difficulties. Br J Psychiatry. 2018;212(1):42–49. PubMed CrossRef
Demyttenaere K, Mortier P, Kiekens G, et al. Is there enough “interest in and pleasure in” the concept of depression? the development of the Leuven Affect and Pleasure Scale (LAPS). CNS Spectr. 2019;24(2):265–274. PubMed CrossRef